Abstract
INTRODUCTION: Sodium valproate, a broad spectrum antiepileptic drug elevates the brain gamma amino butyric acid (GABA) levels by various mechanisms. Behavioral studies in animals have provided additional evidence for interaction between the GABAergic and DAergic systems. Valproate at 200-500mg/kg induces wet dog shake (WDS) behavior in rats. The WDS behavior in rats and head twitch responses (HTR) in mice is evoked by 5-hydroxytryptamine (5-HT, serotonin), the 5-HT precursor, the directly acting non-selective 5-HT receptor agonists and 5-HT releasers. METHOD: In order to determine the GABAergic and 5-HTergic involvement in the induction of WDS behavior in rats the study was taken up to investigate the effect of clomipramine a 5HT depletor, pretreatment on sodium valproate, dexfenfluramine and 5-hydroxytrytamine (5-HTP) induced WDS behavior in rats. OBSERVATION: It was observed that Valproate in the dose range of 200-500mg/kg induced dose dependent WDS in rats. RESULTS: It was observed that pretreatment with PCPA significantly decreased the number of head and whole body shakes in rats caused by valproate and dexfenfluramine. This indicates that the induction of WDS behavior by valproate depends on the availability of brain 5HT and that valproate acts indirectly by releasing 5HT from the 5HTergic neurons.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
